HOME

This class of drug is meant to interfere with the entry, fusion or binding of the HIV virus to a healthy cell.

DHHS Status: Not Recommended

Manufacturer: Genentech (www.gene.com)
Fuzeon (www.fuzeon.com)

FDA approval date: March 13, 2003

Financial Assistance: https://www.gene.com/patients/medicines/fuzeon

The standard dose of Fuzeon is 90mg, which is injected into the upper arm, thigh or abdomen after being reconstituted, or mixed with sterile water, twice a day.
It’s important to rotate the injection site with each dose.

Review: Fuzeon was a “salvage drug” and was first approved by the FDA back in 2003 as a second chance for those who had developed resistance to other HIV drugs. Since then many newer, more effective, cheaper and MUCH more convenient drugs have entered the market. Fuzeon is rarely prescribed anymore.

Copyright 2018, Positive Health Publications, Inc.

This magazine is intended to enhance your relationship with your doctor - not replace it! Medical treatments and products should always be discussed with a licensed physician who has experience treating HIV and AIDS!